Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey.
oleh: Prathiksha Giridharan, Sriram Selvaraju, Raghuram Rao, Kiran Rade, Kannan Thiruvengadam, Smita Asthana, Rakesh Balachandar, Sampada Dipak Bangar, Avi Kumar Bansal, Jyothi Bhat, Debjit Chakraborty, Vishal Chopra, Dasarathi Das, Shanta Dutta, Kangjam Rekha Devi, Sunil Kumar, Avula Laxmaiah, Major Madhukar, Amarendra Mahapatra, Suman Sundar Mohanty, Chethana Rangaraju, Jyotirmayee Turuk, Kamran Zaman, Rajendran Krishnan, Sivakumar Shanmugam, Nishant Kumar, Rajendra Panduranga Joshi, Somashekar Narasimhaiah, Padmapriyadarsini Chandrasekaran, Raman R Gangakhedkar, Balram Bhargava
| Format: | Article |
|---|---|
| Diterbitkan: | Public Library of Science (PLoS) 2023-01-01 |
Deskripsi
Recurrent Tuberculosis patients contribute to a significant proportion of TB burden in India. A nationwide survey was conducted during 2019-2021 across India among adults to estimate the prevalence of TB. A total of 322480 individuals were screened and 1402 were having TB. Of this, 381 (27.1%) had recurrent TB. The crude prevalence (95% CI) of recurrent TB was 118 (107-131) per 100,000 population. The median duration between episodes of TB was 24 months. The proportion of drug resistant TB was 11.3% and 3.6% in the recurrent group and new TB patients respectively. Higher prevalence of recurrent TB was observed in elderly, males, malnourished, known diabetics, smokers, and alcohol users. (p<0.001). To prevent TB recurrence, all treated tuberculosis patients must be followed at least for 24 months, with screening for Chest X-ray, liquid culture every 6 months, smoking cessation, alcohol cessation, nutritional interventions and good diabetic management.